| dc.creator | Kotsiou O.S. | en |
| dc.date.accessioned | 2023-01-31T08:44:43Z | |
| dc.date.available | 2023-01-31T08:44:43Z | |
| dc.date.issued | 2022 | |
| dc.identifier | 10.1016/B978-0-323-85415-3.00013-1 | |
| dc.identifier.isbn | 9780323854153; 9780323854160 | |
| dc.identifier.uri | http://hdl.handle.net/11615/75204 | |
| dc.description.abstract | The last decade has witnessed a growing interest in autoinflammation, which is related to an increase in knowledge about the immunopathogenesis of a broad spectrum of diseases, not only of immunological but also of allergic/inflammatory nature, such as asthma. Contrary to the belief that asthma and autoimmune diseases have little to share, a growing body of research supports autoimmune mechanisms underpinning disease severity in a subset of asthmatics, particularly severe asthmatics. Existing evidence suggests a plausible theory of breach of tolerance in asthma patients. The presence of autoantibodies as a hallmark of autoinflammation and the development of autoimmunity (clinical manifestations caused by autoantibody-mediated inflammation) in asthma are parts of a spectrum of immunological phenomena, following the pattern that innate and adaptive immune responses constitute the immunological continuum. Besides, cutting-edge molecular techniques have revealed common genetic variants between asthma and the wide spectrum of autoimmune diseases. © 2022 Elsevier Inc. All rights reserved. | en |
| dc.language.iso | en | en |
| dc.source | Translational Autoimmunity: Autoimmune Disease Associated with Different Clinical Features | en |
| dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85137908602&doi=10.1016%2fB978-0-323-85415-3.00013-1&partnerID=40&md5=8d261ca3d75bb0fd5d96ad441149e033 | |
| dc.subject | Elsevier | en |
| dc.title | Asthma and autoimmunity | en |
| dc.type | bookChapter | en |